What does PHARMANOUNOU do?

PHARMANOUNOU is filed with the CBE under the catch-all “Overige zakelijke dienstverlening”. Also registered: pharmacy. Private Limited, started on 21 January 2022, 1 establishment.

What is the address of PHARMANOUNOU?

The registered office of PHARMANOUNOU is located at Rue Meloye 10, 4130 Esneux.

Is PHARMANOUNOU still active?

Yes. According to the CBE (31 October 2026) PHARMANOUNOU is active, legal situation “Normale toestand”, started on 21 January 2022.

Is PHARMANOUNOU registered on Peppol?

Yes, PHARMANOUNOU is registered on the Peppol network with ID 0208:0780738548.

What is the enterprise number of PHARMANOUNOU?

The enterprise number of PHARMANOUNOU is BE0780738548.

When was PHARMANOUNOU founded?

PHARMANOUNOU was founded on 21 January 2022.

Who are the directors of PHARMANOUNOU?

According to the 2025 annual accounts, the directors of PHARMANOUNOU are: Mehdi ANOUNOU.

Is PHARMANOUNOU a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 January 2022; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMANOUNOU make in 2025?

PHARMANOUNOU posted a profit after taxes of € 21,425 in financial year 2025.

What is the revenue of PHARMANOUNOU?

As a small company, PHARMANOUNOU is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 35,487.

PHARMANOUNOU (Private Limited) - Esneux - BE0780738548

Dossier PHARMANOUNOU, printed on 31 October 2026 from databakkes.be/en/0780738548/pharmanounou. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMANOUNOU from Esneux, company number BE0780738548, closed financial year 2025 with a result of € 21,425 after tax. For that financial year PHARMANOUNOU recorded a gross margin of € 35,487 and equity of € 52,791. Compared with financial year 2024, the result moved from € 22,623 to € 21,425. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 3, 2026.

What it is worth Healthy

€ 52,791

▼ 14% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 21,425

▼ 5% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 58,275

▼ 24% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 30,245 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 7,564

▼ 37% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 6,572

▼ 44% vs 2024

€ 5,248 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 627

▲ 130% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 18,033

▼ 7% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 22,394 Gross margin 2022: € 22,394 First fiscal year in the series	€ 40,561 Gross margin 2023: € 40,561 ▲ 81% vs 2022 (€ 22,394) Favourable step	€ 36,187 Gross margin 2024: € 36,187 ▼ 11% vs 2023 (€ 40,561) Unfavourable step	€ 35,487 Gross margin 2025: € 35,487 ▼ 2% vs 2024 (€ 36,187) Unfavourable step	▼ 2%
Profit after taxes	€ 13,573 Profit after taxes 2022: € 13,573 First fiscal year in the series	€ 25,907 Profit after taxes 2023: € 25,907 ▲ 91% vs 2022 (€ 13,573) Favourable step	€ 22,623 Profit after taxes 2024: € 22,623 ▼ 13% vs 2023 (€ 25,907) Unfavourable step	€ 21,425 Profit after taxes 2025: € 21,425 ▼ 5% vs 2024 (€ 22,623) Unfavourable step	▼ 5%
Equity	€ 14,773 Equity 2022: € 14,773 First fiscal year in the series	€ 39,847 Equity 2023: € 39,847 ▲ 170% vs 2022 (€ 14,773) Favourable step	€ 61,611 Equity 2024: € 61,611 ▲ 55% vs 2023 (€ 39,847) Favourable step	€ 52,791 Equity 2025: € 52,791 ▼ 14% vs 2024 (€ 61,611) Unfavourable step	▼ 14%
Total debts	€ 39,554 Total debts 2022: € 39,554 First fiscal year in the series	€ 35,752 Total debts 2023: € 35,752 ▼ 10% vs 2022 (€ 39,554) Favourable step	€ 34,740 Total debts 2024: € 34,740 ▼ 3% vs 2023 (€ 35,752) Favourable step	€ 28,262 Total debts 2025: € 28,262 ▼ 19% vs 2024 (€ 34,740) Favourable step	▼ 19%
Cash	€ 20,634 Cash 2022: € 20,634 First fiscal year in the series	€ 48,273 Cash 2023: € 48,273 ▲ 134% vs 2022 (€ 20,634) Favourable step	€ 77,010 Cash 2024: € 77,010 ▲ 60% vs 2023 (€ 48,273) Favourable step	€ 58,275 Cash 2025: € 58,275 ▼ 24% vs 2024 (€ 77,010) Unfavourable step	▼ 24%
Retained profit	€ 12,773 Retained profit 2022: € 12,773 First fiscal year in the series	€ 37,847 Retained profit 2023: € 37,847 ▲ 196% vs 2022 (€ 12,773) Favourable step	€ 59,611 Retained profit 2024: € 59,611 ▲ 58% vs 2023 (€ 37,847) Favourable step	€ 50,791 Retained profit 2025: € 50,791 ▼ 15% vs 2024 (€ 59,611) Unfavourable step	▼ 15%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 833 Dividend 2023: € 833 Unchanged (€ 0) Unchanged	€ 859 Dividend 2024: € 859 ▲ 3% vs 2023 (€ 833) Unchanged	€ 30,245 Dividend 2025: € 30,245 ▲ € 29,386 vs 2024 (€ 859) Unchanged	▲ € 29,386
Bank debt	€ 22,586 Bank debt 2022: € 22,586 First fiscal year in the series	€ 16,819 Bank debt 2023: € 16,819 ▼ 26% vs 2022 (€ 22,586) Favourable step	€ 11,737 Bank debt 2024: € 11,737 ▼ 30% vs 2023 (€ 16,819) Favourable step	€ 6,572 Bank debt 2025: € 6,572 ▼ 44% vs 2024 (€ 11,737) Favourable step	▼ 44%
Balance sheet total	€ 54,327 Balance sheet total 2022: € 54,327 First fiscal year in the series	€ 75,599 Balance sheet total 2023: € 75,599 ▲ 39% vs 2022 (€ 54,327) Unchanged	€ 96,351 Balance sheet total 2024: € 96,351 ▲ 27% vs 2023 (€ 75,599) Unchanged	€ 81,052 Balance sheet total 2025: € 81,052 ▼ 16% vs 2024 (€ 96,351) Unchanged	▼ 16%

Key figures of PHARMANOUNOU, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMANOUNOU?

What happened at PHARMANOUNOU in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 3, 2026 New annual accounts for financial year 2025: profit of € 21,425 (▼ 5% vs 2024). Source: NBB ↗
Jan 21, 2022 New establishment in Liège. KBO
2022 Mehdi ANOUNOU became a director. NBB
Jan 21, 2022 Start of the company according to the CBE. KBO

In short

From € 13,573 profit in 2022 to € 21,425 profit in 2025.

Paid € 26,460 in corporate taxes since 2022.

Best year ever: 2023, with € 25,907 profit.

Paid out € 31,937 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Mehdi ANOUNOU

PHARMANOUNOU

Behind PHARMANOUNOU is Mehdi ANOUNOU.

Directors

According to the 2025 annual accounts

Mehdi ANOUNOU

Director

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Meloye 10

4130 Esneux

2.326.940.126

Rue de Sélys 17 box 11

4000 Liège

Active since 21 January 2022

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0780.738.548

VAT number

BE 0780.738.548

Registered office

Rue Meloye 10, 4130 Esneux

Names & denominations

PHARMANOUNOU

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

21 January 2022

Peppol

Active · Active since 7 Feb 2022

Activities · NACE

Overige zakelijke dienstverlening, neg

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMANOUNOU

Financials

What happened to PHARMANOUNOU?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions